ISIS PHARMACEUTICALS INC's ticker is ISIS and the CUSIP is 464330109. A total of 4 filers reported holding ISIS PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $1,213,000 | +40.6% | 30,000 | +100.0% | 0.05% | +58.8% |
| Q2 2015 | $863,000 | +171.4% | 15,000 | +200.0% | 0.03% | +142.9% |
| Q1 2015 | $318,000 | +2.9% | 5,000 | 0.0% | 0.01% | +27.3% |
| Q4 2014 | $309,000 | -20.4% | 5,000 | -50.0% | 0.01% | +22.2% |
| Q3 2014 | $388,000 | -40.1% | 10,000 | -46.8% | 0.01% | -35.7% |
| Q2 2014 | $648,000 | +70.5% | 18,800 | +113.6% | 0.01% | +75.0% |
| Q1 2014 | $380,000 | -52.8% | 8,800 | -56.5% | 0.01% | -55.6% |
| Q4 2013 | $805,000 | +7.3% | 20,210 | +1.0% | 0.02% | +125.0% |
| Q3 2013 | $750,000 | – | 20,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BB BIOTECH AG | 6,636,526 | $257,696,000 | 10.48% |
| WILLIAM HARRIS INVESTORS INC | 309,934 | $12,034,000 | 3.60% |
| DOWLING & YAHNKE LLC | 676,298 | $26,261,000 | 3.46% |
| GRAYBILL WEALTH MANAGEMENT, LTD. | 90,240 | $3,504,000 | 2.69% |
| HWG Holdings LP | 58,395 | $2,267,000 | 1.82% |
| Iguana Healthcare Management, LLC | 85,000 | $3,300,000 | 1.76% |
| PINNACLE ASSOCIATES LTD | 1,845,727 | $71,670,000 | 1.46% |
| Adamant Biomedical Investments AG | 140,000 | $5,436,000 | 1.36% |
| Apex Capital Management | 843,791 | $32,764,000 | 0.99% |
| PERKINS CAPITAL MANAGEMENT INC | 28,465 | $1,105,000 | 0.93% |